Guilford stock bought

November 09, 1994|By a Sun Staff Writer

Trying to boost confidence in the fledgling company, directors and officers of Guilford Pharmaceuticals Inc. have bought in the open market 102,100 shares of common stock, or about 3 percent of the outstanding shares.

The purchases were made between Oct. 19 and Oct. 27, when the stock was selling for between $2.625 and $3.50 a share.

Guilford shares closed yesterday at $3.125, up 37.5 cents.

The Baltimore-based company, which is working on drugs for diseases of the brain, also announced yesterday that two new investment firms are making markets in its stock -- Hambrecht & Quist of New York and Josephthal, Lyon & Ross, also based in New York.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.